Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenaya Hooks

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|July 31, 2025
IL-2 and IL-15 augment HBV therapeutic vaccination and PD1 blockade for functional cure in the AAV-HBV mouse modelGavin Lewis, Kirsten Malo, Thomas Rowland, et al.
Frontiers in Pediatrics|November 16, 2020
Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant RecipientsCorina Nailescu, Myda Khalid, Amy C Wilson, et al.
Frontiers in Pediatrics|May 17, 2021
Placement on COVID-19 Units Does Not Increase Seroconversion Rate of Pediatric Graduate Medical ResidentsTimothy Crisci, Samuel Arregui, Jorge Canas, et al.
Pathogens & Immunity|February 18, 2022
A Pilot Single Cell Analysis of the Zebrafish Embryo Cellular Responses to Uropathogenic <i>Escherichia coli</i> InfectionAshley Rawson, Vijay Saxena, Hongyu Gao, et al.
Innate Immunity|April 17, 2020
<i>DCHS1</i> DNA copy number loss associated with pediatric urinary tract infection riskAslam H Qureshi, Dong Liang, Jorge Canas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2022
Human neutrophil peptides 1-3 protect the murine urinary tract from uropathogenic <i>Escherichia coli</i> challengeJorge J Canas, Dong Liang, Vijay Saxena, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|July 31, 2025
IL-2 and IL-15 augment HBV therapeutic vaccination and PD1 blockade for functional cure in the AAV-HBV mouse modelGavin Lewis, Kirsten Malo, Thomas Rowland, et al.
Frontiers in Pediatrics|November 16, 2020
Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant RecipientsCorina Nailescu, Myda Khalid, Amy C Wilson, et al.
Frontiers in Pediatrics|May 17, 2021
Placement on COVID-19 Units Does Not Increase Seroconversion Rate of Pediatric Graduate Medical ResidentsTimothy Crisci, Samuel Arregui, Jorge Canas, et al.
Pathogens & Immunity|February 18, 2022
A Pilot Single Cell Analysis of the Zebrafish Embryo Cellular Responses to Uropathogenic <i>Escherichia coli</i> InfectionAshley Rawson, Vijay Saxena, Hongyu Gao, et al.
Innate Immunity|April 17, 2020
<i>DCHS1</i> DNA copy number loss associated with pediatric urinary tract infection riskAslam H Qureshi, Dong Liang, Jorge Canas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2022
Human neutrophil peptides 1-3 protect the murine urinary tract from uropathogenic <i>Escherichia coli</i> challengeJorge J Canas, Dong Liang, Vijay Saxena, et al.
Pageof 1